<Record>
<Term>Tetrahydrozoline</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Alpha-Adrenergic Agonist</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Adrenergic Agent/Alpha-Adrenergic Agonist/Tetrahydrozoline</ClassificationPath>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Adrenergic Agent/Alpha-Adrenergic Agonist/Tetrahydrozoline Hydrochloride</ClassificationPath>
<BroaderTerm>Tetrahydrozoline Hydrochloride</BroaderTerm>
<BroaderTerm>Tetrahydrozoline</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Adrenergic Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Alpha-Adrenergic Agonist</BroaderTerm>
<Synonym>2-(1,2,3,4-Tetrahydro-1-naphthyl)-2-imidazoline Hydrochloride</Synonym>
<Synonym>Tetrahydrozoline Hydrochloride</Synonym>
<Synonym>Vasopos</Synonym>
<Synonym>Visine</Synonym>
<Synonym>Tetrahydrozoline hydrochloride</Synonym>
<Synonym>Tetrahydrozoline</Synonym>
<Synonym>TETRAHYDROZOLINE HYDROCHLORIDE</Synonym>
<Synonym>1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, Monohydrochloride</Synonym>
<Synonym>Tyzanol Hydrochloride</Synonym>
<Synonym>Tyzine</Synonym>
<Synonym>TETRAHYDROZOLINE</Synonym>
<Description>An imidazole derivative with sympathomimetic activity. Applied locally to the eye or nose, tetrahydrozoline binds to and activates alpha-adrenergic receptors, resulting in vasoconstriction and decreased nasal and ophthalmic congestion.</Description>
<Description>The hydrochloride salt form of tetrahydrozoline, an imidazole derivative with sympathomimetic property. Applied locally to the eye or nose, tetrahydrozoline binds to and activates alpha-adrenergic receptors, resulting in vasoconstriction and decreased nasal and ophthalmic congestion.</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
